Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metastatic cancer from sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Head and Neck Cancer
• Or Metastatic Cancer
• Pancreatic Cancer
• Testicular Cancer

Drugs mentioned

• FalateScan (Technetium Tc 99m EC20)

Snippet

Sponsor: Endocyte | Conditions: Recurrent or Metastatic Cancer, Head and Neck Cancer | Phase 2 | Status: COMPLETED